Pancreatic Cancer Research

ResearcherUniversidad Complutense de MadridNo recent work listed

Felipe Ángel Calvo Manuel

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-7574-546X; OpenAlex author ID A5032986745. Sources: OpenAlex.

Their work

Papers
8 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
30
Papers, trials and grants by year

2013: 1 paper · 2014: 1 paper · 2015: 2 papers · 2016: none · 2017: none · 2018: none · 2019: 2 papers · 2020: 2 papers

Papers 8

  1. ESTRO IORT Task Force/ACROP recommendations for intraoperative radiation therapy in borderline-resected pancreatic cancer. Co-author DOI 10.1016/j.ctro.2020.05.005↗
  2. ESTRO IORT Task Force/ACROP recommendations for intraoperative radiation therapy in unresected pancreatic cancer. Co-author DOI 10.1016/j.radonc.2020.03.040↗
  3. Prognostic Impact of Presurgical CA19-9 Level in Pancreatic Adenocarcinoma: A Pooled Analysis. Co-author DOI 10.1016/j.tranon.2018.08.017↗
  4. Adjuvant chemoradiation in pancreatic cancer: impact of radiotherapy dose on survival. Co-author DOI 10.1186/s12885-019-5790-2↗
  5. Role of radiotherapy in the chemotherapy-containing multidisciplinary management of patients with resected pancreatic adenocarcinoma. First author DOI 10.1007/s00066-014-0759-1↗
  6. Adjuvant Chemoradiation in Pancreatic Cancer: A Pooled Analysis in Elderly (≥75 years) Patients. Co-author PMID 26026108↗
  7. Multi-institutional pooled analysis on adjuvant chemoradiation in pancreatic cancer. Co-author DOI 10.1016/j.ijrobp.2014.07.024↗
  8. Chemoradiation for resected pancreatic adenocarcinoma with or without intraoperative radiation therapy boost: Long-term outcomes. Co-author DOI 10.1016/j.pan.2013.09.002↗

Closest collaborators

The 25 strongest of 30 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Philip M. Poortmans · 2 shared papers, 2020 · strength 0.24
  2. Robert C Krempien · 2 shared papers, 2020 · strength 0.24
  3. Marco Krengli · 2 shared papers, 2020 · strength 0.24
  4. José Manuel Asencio Pascual · 2 shared papers, 2020 · strength 0.24
  5. Frank W. Hensley · 2 shared papers, 2020 · strength 0.24
  6. Falk Roeder · 2 shared papers, 2020 · strength 0.24
  7. William F. Regine · 4 shared papers, 2014–2019 · strength 0.21
  8. Gian Carlo Mattiucci · 4 shared papers, 2014–2019 · strength 0.21
  9. Robert Clell Miller · 4 shared papers, 2014–2019 · strength 0.21
  10. Alessio Giuseppe Morganti · 4 shared papers, 2014–2019 · strength 0.21
  11. Sergio Alfieri · 4 shared papers, 2014–2019 · strength 0.21
  12. Joseph M. Herman · 4 shared papers, 2014–2019 · strength 0.21
  13. Vincenzo Valentini · 4 shared papers, 2014–2019 · strength 0.21
  14. Massimo Falconi · 4 shared papers, 2014–2019 · strength 0.21
  15. Michele Reni · 4 shared papers, 2014–2019 · strength 0.21
  16. Lorenzo Fuccio · 2 shared papers, 2019 · strength 0.14
  17. Riccardo Casadei · 2 shared papers, 2019 · strength 0.14
  18. Gabriella Macchia · 2 shared papers, 2019 · strength 0.14
  19. Milly Buwenge · 2 shared papers, 2019 · strength 0.14
  20. Francesco Cellini · 2 shared papers, 2019 · strength 0.14
  21. Francesco Minni · 2 shared papers, 2019 · strength 0.14
  22. Alessandra Arcelli · 2 shared papers, 2019 · strength 0.14
  23. Stefano Partelli · 2 shared papers, 2015–2019 · strength 0.11
  24. Jose Luis Garcia-Sabrido · 2 shared papers, 2013–2015 · strength 0.09
  25. Claudio V. Sole · 2 shared papers, 2013–2015 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.